PP-7-18 Paclitaxel combinations with weekly high dose 5-FU/Folinic acid and cisplatin in the treatment of metastatic breast cancer — there is a possible role of combining paclitaxel with anthracycline non cross resistant chemotherapeutic agents in the first and second line treatment I
- 1 January 1996
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 32, 48
- https://doi.org/10.1016/0959-8049(96)84235-3